Correlation Between Dyadic International and Theriva Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dyadic International and Theriva Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyadic International and Theriva Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyadic International and Theriva Biologics, you can compare the effects of market volatilities on Dyadic International and Theriva Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyadic International with a short position of Theriva Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyadic International and Theriva Biologics.

Diversification Opportunities for Dyadic International and Theriva Biologics

0.2
  Correlation Coefficient

Modest diversification

The 3 months correlation between Dyadic and Theriva is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Dyadic International and Theriva Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Theriva Biologics and Dyadic International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyadic International are associated (or correlated) with Theriva Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Theriva Biologics has no effect on the direction of Dyadic International i.e., Dyadic International and Theriva Biologics go up and down completely randomly.

Pair Corralation between Dyadic International and Theriva Biologics

Given the investment horizon of 90 days Dyadic International is expected to generate 0.73 times more return on investment than Theriva Biologics. However, Dyadic International is 1.38 times less risky than Theriva Biologics. It trades about 0.32 of its potential returns per unit of risk. Theriva Biologics is currently generating about 0.0 per unit of risk. If you would invest  107.00  in Dyadic International on August 30, 2024 and sell it today you would earn a total of  66.00  from holding Dyadic International or generate 61.68% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Dyadic International  vs.  Theriva Biologics

 Performance 
       Timeline  
Dyadic International 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Dyadic International are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite fairly conflicting basic indicators, Dyadic International demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Theriva Biologics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Theriva Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Dyadic International and Theriva Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dyadic International and Theriva Biologics

The main advantage of trading using opposite Dyadic International and Theriva Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyadic International position performs unexpectedly, Theriva Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Theriva Biologics will offset losses from the drop in Theriva Biologics' long position.
The idea behind Dyadic International and Theriva Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.